Page last updated: 2024-08-18

allylamine and Lung Neoplasms

allylamine has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henney, JE1
Chen, GA; Lorang, D; Nguyen, DM; Schrump, DS; Stewart, JH; Tabibi, E1

Other Studies

2 other study(ies) available for allylamine and Lung Neoplasms

ArticleYear
From the Food and Drug Administration.
    JAMA, 2000, Aug-09, Volume: 284, Issue:6

    Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogels; Hypercholesterolemia; Lung Neoplasms; Surgical Equipment; United States; United States Food and Drug Administration

2000
Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:2

    Topics: Allylamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Benzothiazoles; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Synergism; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Lactams, Macrocyclic; Lung Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Quinones; Tumor Cells, Cultured; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001